Walder Wyss advised RealWear on this transaction. RealWear, the global leader in wearable computing for industrial applications, acquired Almer Technologies, a Swiss pioneer in ultra-compact, user-friendly...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised 14Trees on this transaction. 14Trees completed an exclusive Series A-1 round backed by Amazon’s Climate Pledge Fund, alongside founding investor Holcim. The joint...
You must be a Standard 1 Year member to access this content.
Niederer Kraft Frey advised Cherry Ventures while, Walder Wyss acted for Voliro AG. Voliro completed its $12 million series A investment round led by Cherry Ventures, a...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised International Football Management in this transaction. Wasserman, a global sports, music and entertainment company, has acquired International Football Management (IFM). IFM has been...
You must be a Standard 1 Year member to access this content.
Walder Wyss has advised ENANTIOS on this transaction. ENANTIOS, an ETH Zurich deep-tech Spin-off, has announced the completion of its seed financing round. The ENANTIOS technology,...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Tertianum on the acquisition. The residential and care center Foundation Clair-Logis, based in Delémont, has become part of the Tertianum Group. Tertianum is...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the buyer on the deal. A joint partnership among Trinity Investments, funds managed by Oaktree Capital Management, and funds managed by UBS Asset...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Cultivated Biosciences on this transaction. Cultivated Biosciences SA, a Swiss Start-Up developing a creamy, dairy-free and animal free solution/ingredient, has announced the successful...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Nasdaq listed Altamira Therapeutics. Altamira Therapeutics Ltd. (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, entered into a binding...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Andera Partners on the Swiss legal and tax diligence aspects of this transaction. The Auris Group has reorganised its capital with the support...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Andera Partners on the Swiss legal and tax diligence aspects of this transaction. The Auris Group has reorganised its capital with the support...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Token Flow Insights SA on the deal. Token Flow Insights SA has completed the first close of its Series A financing round with...
You must be a Standard 1 Year member to access this content.
